Umjovo wehepatitis A
Umjovo wehepatitis A ngumjovo lovikela ihepatitis A.[1] Usebente kahle kakhulu kubantfu labagulako labangu 95% kantsi ube khona lokungenani iminyaka lelishumi nesihlanu nesikhatsi umuntfu langahle asiphile.[1][2] Uma uniketwa, emadosi lamabili ayaconywa ekucaleni ngemuva kwemnyaka munye. Uniketwa ngekukujova emsipheni.[1]
Inhlangano Yetemphilo Mhlabawonkhe (i-WHO) incoma imijova lesebenta ndzawotonkhe etindzaweni lapho ungakavami kangako. Lapho lesifo sijwayeleke khona imijovo lesabalele ayinconywa njengoba bonkhe bantfu bavame kungenwa kusuleleka ngetifo ngemntfwana.[1] Sikhungo Lesilawula Nalesivikela Tifo (i-CDC) incoma kujovwa kwebantfu labadzala labasengotini kakhulu nabo bonkhe bantfwana.[3]
Imitselela lemibi lecacile ayikavamisi kwenteka. Kuba khona tinhlungu kulelicala lelijoviwe lobulinganiselwa ku-15% kubantfwana nehhafu yebantfu labadzala. Imijovo leminyenti yehepatitis A icuketse emagciwane langaphili ngalesikhatsi leminye inemagciwane langenamandla. Lena lenemagciwane lengenamandla akufanele itsatfwe ngalesikhatsi ukhulelwe noma kulabo labanemasotja langasebenti kahle. Kwakheka lokumbalwa kwenhlanganisela yehepatitis A mhlawumbe nehepatitis B noma umjovo wethayifodi.[1]
Umjovo wekucala we-A wavunyelwa e-Europe nga-1991 nase United States nga-1995.[4] KukuLuhla Lwemitsi Lebalulekile Lwenhlangano Yetemphilo Mhlabawonkhe, umutsi lobaluleke kakhulu lodzingekako kuloluhlelo lolusisekelo lwetemphilo.[5] E-United States ubita emkhatsini wa-50 na 100 USD.[6] Template:Drugbox
Emareferensi[hlela | edit source]
- ↑ 1.0 1.1 1.2 1.3 1.4 "WHO position paper on hepatitis A vaccines – June 2012" (PDF). Wkly Epidemiol Rec. 87 (28/29): 261-76. 2012 Jul 13. PMID 22905367.
- ↑ Ott JJ, Irving G, Wiersma ST (December 2012). "Long-term protective effects of hepatitis A vaccines. A systematic review". Vaccine. 31 (1): 3–11. doi:10.1016/j.vaccine.2012.04.104. PMID 22609026.
- ↑ "Hepatitis A In-Short". CDC. July 25, 2014. Retrieved 7 December 2015.
- ↑ Patravale, Vandana; Dandekar, Prajakta; Jain, Ratnesh (2012). Nanoparticulate drug delivery perspectives on the transition from laboratory to market (1. publ. ed.). Oxford: Woodhead Pub. p. 212. ISBN 9781908818195.
- ↑ "19th WHO Model List of Essential Medicines (April 2015)" (PDF). WHO. April 2015. Retrieved May 10, 2015.
- ↑ Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 314. ISBN 9781284057560.